Transient bone marrow oedema syndrome in an HIV-infected patient on highly active antiretroviral therapy

被引:0
|
作者
Vera, J. H. [1 ]
Walker, A. E. [2 ]
Kinderlerer, A. [3 ]
Cooke, G. S. [4 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Infect Dis, London, England
[2] St Marys Hosp, Dept Radiol, London, England
[3] St Marys Hosp, Dept Rheumatol, London, England
[4] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Imperial Coll London, Dept Infect Dis, Durban, South Africa
关键词
HIV; bone marrow oedema syndrome; BMES; tenofovir; antiretroviral; REGIONAL MIGRATORY OSTEOPOROSIS; OF-THE-LITERATURE; AVASCULAR NECROSIS; OSTEONECROSIS;
D O I
10.1258/ijsa.2009.009358
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bone marrow oedema syndrome (BMES, also known as transient osteoporosis) is an uncommon, self-limiting condition characterized by disabling pain, reversible osteopaenia on X-rays and by bone marrow oedema pattern on magnetic resonance imaging (MRI). Here we describe the first reported case of BMES in an HIV-positive patient on highly active antiretroviral therapy.
引用
收藏
页码:213 / 215
页数:3
相关论文
共 50 条
  • [31] Immunological nonresponse to highly active antiretroviral therapy in HIV-infected subjects: Is the bone marrow impairment causing CD4 lymphopenia?
    Badolato, Raffaele
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) : 1911 - 1912
  • [32] Prolonged Paradoxical Reaction of Tuberculosis in an HIV-Infected Patient after Initiation of Highly Active Antiretroviral Therapy
    A. Ramos
    A. Asensio
    I. Perales
    M. C. Montero
    T. Martín
    [J]. European Journal of Clinical Microbiology and Infectious Diseases , 2003, 22 : 374 - 376
  • [33] Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient
    Kumarasamy, N.
    Venkatesh, K. K.
    Devaleenol, B.
    Poongulali, S.
    Ahilasamy, N.
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2008, 19 (11) : 786 - 788
  • [34] Toxoplasma encephalitis in an HIV-infected patient on highly active antiretroviral therapy despite sustained immune response
    Atreya, Auras R.
    Arora, Sonali
    Gadiraju, Vijay T.
    Martagon-Villamil, Jose
    Skiest, Daniel J.
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2014, 25 (05) : 383 - 386
  • [35] Prolonged paradoxical reaction of tuberculosis in an HIV-infected patient after initiation of highly active antiretroviral therapy
    Ramos, A
    Asensio, A
    Perales, I
    Montero, MC
    Martín, T
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (06) : 374 - 376
  • [36] Alternative therapy use in HIV-infected patients receiving highly active antiretroviral therapy
    Risa, KJ
    Nepon, L
    Justis, JC
    Panwalker, A
    Berman, SM
    Cinti, S
    Wagener, MM
    Singh, N
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (10) : 706 - 713
  • [37] Directly observed highly active antiretroviral therapy for HIV-infected children in Cambodia
    Myung, Patricia
    Pugatch, David
    Brady, Mark F.
    Many, Phok
    Harwell, Joseph I.
    Lurie, Mark
    Tucker, John
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2007, 97 (06) : 974 - 977
  • [38] Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
    Dean, GL
    Edwards, SG
    Ives, NJ
    Matthews, G
    Fox, EF
    Navaratne, L
    Fisher, M
    Taylor, GP
    Miller, R
    Taylor, CB
    de Ruiter, A
    Pozniak, AL
    [J]. AIDS, 2002, 16 (01) : 75 - 83
  • [39] Appendicitis in HIV-infected patients during the era of highly active antiretroviral therapy
    Crum-Cianflone, N.
    Weekes, J.
    Bavaro, M.
    [J]. HIV MEDICINE, 2008, 9 (06) : 421 - 426
  • [40] Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy
    Sevastianova, K
    Sutinen, J
    Westerbacka, J
    Ristola, M
    Yki-Järvinen, H
    [J]. ANTIVIRAL THERAPY, 2005, 10 (08) : 925 - 935